Table 2.
Group allergen * | Cross-staining I | Full-scale cross-reactivity II | Partial cross-reactivity II | ’ Minimal cross-reactivity II |
---|---|---|---|---|
Group 1 97-116 | Pha a 1 and Phl p 1 | X | ||
Poa p 1 and Phl p 1 | X | |||
Lol p 1 and Phl p 1 | X | |||
Group 1 221-240 | Dac g 1 and Phl p 1 | X | ||
Poa p 1 and Phl p 1 | X | |||
Lol p 1 and Phl p 1 | X | |||
Group 5 167-186 | Dac g 5a and Phl p 5a | X | ||
Pha a 5a and Phl p 5a | X | |||
Poa p 5a and Phl p 5a | X | |||
Lol p 5a and Phl p 5a | X | |||
Hol l 5a and Phl p 5a | X | |||
Hor v 5a and Phl p 5a | X | |||
Group 5 199-218 | Dac g 5a and Phl p 5a | X | ||
Pha a 5a and Phl p 5a | X | |||
Poa p 5a and Phl p 5a | X | |||
Lol p 5a and Phl p 5a | X | |||
Hol l 5a and Phl p 5a | X | |||
Hor v 5a and Phl p 5a | X |
Group 1 refers to isoform 0102; Group 5a refers to isoform 0101 and 5b to isoform 0102.
The first epitope listed is the stimulatory epitope; the second epitope listed is the cross-stained epitope.
Cross-reactivity assessed on the basis of tetramer co-staining experiments.